Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Return on Capital Employed (2018 - 2025)

Cue Biopharma (CUE) has disclosed Return on Capital Employed for 8 consecutive years, with 0.23% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 11.0% to 0.23% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.23% through Dec 2025, up 11.0% year-over-year, with the annual reading at 0.23% for FY2025, 3.0% up from the prior year.
  • Return on Capital Employed hit 0.23% in Q4 2025 for Cue Biopharma, up from 0.25% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.23% in Q4 2025 to a low of 1.71% in Q3 2024.
  • Historically, Return on Capital Employed has averaged 0.77% across 5 years, with a median of 0.67% in 2022.
  • Biggest five-year swings in Return on Capital Employed: crashed -72bps in 2024 and later surged 145bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.64% in 2021, then decreased by -15bps to 0.74% in 2022, then crashed by -47bps to 1.08% in 2023, then skyrocketed by 68bps to 0.34% in 2024, then surged by 32bps to 0.23% in 2025.
  • Business Quant data shows Return on Capital Employed for CUE at 0.23% in Q4 2025, 0.25% in Q3 2025, and 0.53% in Q2 2025.